| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/28/2003 | US20030162209 PCR based high throughput polypeptide screening |
| 08/28/2003 | US20030162206 Central nervous system disorders; antiinflammatory agnets; antidiabetic agents |
| 08/28/2003 | US20030162205 Novel transcription factor having zinc finger domain |
| 08/28/2003 | US20030162203 Medical diagnosis using chromosomes, nucleic acids |
| 08/28/2003 | US20030162201 Cloned DNA polymerases from Thermotoga and mutants thereof |
| 08/28/2003 | US20030162200 Methods for modulating telomerase activity |
| 08/28/2003 | US20030162197 Method of detecting neoplastic or non-neoplastic cells |
| 08/28/2003 | US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 08/28/2003 | US20030162194 Diagnosis of diseases associated with apoptosis |
| 08/28/2003 | US20030162193 Screening ratio between lipoxygenase and lipase enzymes |
| 08/28/2003 | US20030162192 Polymorphisms associated with ion-channel disease |
| 08/28/2003 | US20030162191 Enzyme inhibitors; microbiocides, antiinflamamtory agents, viricides, antitumor agents; gene therapy |
| 08/28/2003 | US20030162189 Adjust gene expression; genetic engineering; antiproliferative agents |
| 08/28/2003 | US20030162188 Nucleic acids; bacteria artificial chromosomes |
| 08/28/2003 | US20030162185 Products comprising a support to which nucleic acids are fixed and their use as dna chips |
| 08/28/2003 | US20030162184 Amplification; polymerase chain reactions |
| 08/28/2003 | US20030162180 Calibrating test pattern; hybrid primers |
| 08/28/2003 | US20030162176 Complementary DNAs |
| 08/28/2003 | US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies |
| 08/28/2003 | US20030162174 Detecting nucleic acid deletion sequences |
| 08/28/2003 | US20030162173 Nucleic acid modifying enzymes |
| 08/28/2003 | US20030162170 Nucleic acids; antibody, antigen complex |
| 08/28/2003 | US20030162169 Screening enzyme inhibitors |
| 08/28/2003 | US20030162168 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease |
| 08/28/2003 | US20030162167 Hepatitis c virusl detection using Dna sequences; liver disorders; immunoassay |
| 08/28/2003 | US20030161845 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine |
| 08/28/2003 | US20030161844 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 08/28/2003 | US20030161838 A highly purified protein, Plasmodium falciparum MSP-142, which retains folding and disulfide bridging of the native molecule and is useful as a diagnostic reagent, antibody production, and as a vaccine for malaria |
| 08/28/2003 | US20030161836 Biological materials and methods useful in the diagnosis and treatment of diseases |
| 08/28/2003 | US20030161835 Polypeptides from moraxella (branhamella) catarrhalis |
| 08/28/2003 | US20030161834 Adjuvant compositions comprising a saponin and and an immunostimulatory oligonucleotide containing unmethylated CpG (a cytosine guanosine dinucleotide DNA motif); synergistic induction of antigen; anticarcinogenic agents |
| 08/28/2003 | US20030161833 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/28/2003 | US20030161832 Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen |
| 08/28/2003 | US20030161826 Therapy for autoimmune disease; central nervous system disorders |
| 08/28/2003 | US20030161819 Genetic engineering; promoters; deactivation of major histocompatibility complex |
| 08/28/2003 | US20030161814 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles |
| 08/28/2003 | US20030161809 Complexes; drug delivery |
| 08/28/2003 | DE10232507C1 Sequence-controlled synthesis of nucleic acids, useful for making synthetic genes, comprises hybridizing primers to both strands then filling in gaps using a nucleic acid polymerase system |
| 08/28/2003 | CA2775650A1 Decreased reducing sugars in plants for the reduction of acrylamide production in heated foods |
| 08/28/2003 | CA2515243A1 Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent |
| 08/28/2003 | CA2513192A1 Nucleotide sequence coding for a tolc and a defined amino acid sequence |
| 08/28/2003 | CA2487395A1 Method for discovering pharmacologically active substances |
| 08/28/2003 | CA2486388A1 Novel fungal lipase |
| 08/28/2003 | CA2485882A1 A therapeutic agent for mycobacterium tuberculosis comprising 15k granulysin as the active ingredient |
| 08/28/2003 | CA2483646A1 Fluorescent protein |
| 08/28/2003 | CA2480771A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof |
| 08/28/2003 | CA2477820A1 Polynucleotide for target gene |
| 08/28/2003 | CA2477345A1 Methods for two-dimensional conformation-dependent separation of non-circular nucleic acids |
| 08/28/2003 | CA2477202A1 Cd40 splice variants, compositions for making and methods of using the same |
| 08/28/2003 | CA2477195A1 Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 08/28/2003 | CA2477159A1 Highly homogeneous molecular markers for electrophoresis |
| 08/28/2003 | CA2477017A1 Selective extraction of dna from groups of cells |
| 08/28/2003 | CA2477014A1 Rna interference mediated inhibition of tnf and tnf receptor superfamily gene expression using short interfering nucleic acid (sina) |
| 08/28/2003 | CA2477012A1 Anti-a.beta. antibodies and their use |
| 08/28/2003 | CA2476894A1 Transgenic production in saliva |
| 08/28/2003 | CA2476854A1 Surrogate antibodies and methods of preparation and use thereof |
| 08/28/2003 | CA2476835A1 A non-invasive diagnostic test utilizing histone modification markers |
| 08/28/2003 | CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 08/28/2003 | CA2476761A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors |
| 08/28/2003 | CA2476625A1 Mhc-peptide complex binding ligands |
| 08/28/2003 | CA2476452A1 Electroporation methods for introducing bioactive agents into cells |
| 08/28/2003 | CA2476451A1 Hyaluronic acid mediated adenoviral transduction |
| 08/28/2003 | CA2476437A1 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2003 | CA2476434A1 Method of treating trx mediated diseases |
| 08/28/2003 | CA2476394A1 Rna interference mediated inhibition of hiv gene expression using short interfering nucleic acid (sina) |
| 08/28/2003 | CA2476376A1 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 08/28/2003 | CA2476365A1 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
| 08/28/2003 | CA2476309A1 Methods and reagents for detecting target binding by nucleic acid ligands |
| 08/28/2003 | CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina) |
| 08/28/2003 | CA2476100A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/28/2003 | CA2475540A1 Heat stable mutants of starch biosynthesis enzymes |
| 08/28/2003 | CA2475451A1 Method of separation using aromatic thioether ligands |
| 08/28/2003 | CA2475188A1 Mismatch repair detection |
| 08/28/2003 | CA2474802A1 Process for producing levodione |
| 08/28/2003 | CA2474589A1 Methods for altering organ mass in plants |
| 08/28/2003 | CA2473922A1 Bacteria with reduced genome |
| 08/28/2003 | CA2473133A1 Rrp sequences and knockout mice and uses thereof |
| 08/28/2003 | CA2471421A1 Rna interference mediated inhibition of protein typrosine phosphatase-1b (ptp-1b) gene expression using short interfering nucleic acid (sina) |
| 08/28/2003 | CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina) |
| 08/28/2003 | CA2460055A1 Insulin and igf-1 receptor agonists and antagonists |
| 08/28/2003 | CA2459532A1 Rna interference by modified short interfering nucleic acid |
| 08/28/2003 | CA2456444A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina) |
| 08/28/2003 | CA2456204A1 Methods for attaching nucleic acid molecules to electrically conductive surfaces |
| 08/28/2003 | CA2455506A1 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina) |
| 08/28/2003 | CA2380471A1 Oral dna vaccine composition for hepatitis b virus chronic infection |
| 08/28/2003 | CA2373903A1 Increasing plant seed production |
| 08/27/2003 | EP1338896A2 ICAM-4 and diagnostic uses thereof |
| 08/27/2003 | EP1338657A1 Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines |
| 08/27/2003 | EP1338654A1 Process for producing nucleoside compound |
| 08/27/2003 | EP1338653A2 Improvement of an expression vector for production of recombinant proteins |
| 08/27/2003 | EP1338652A2 Plant cell cyclin genes |
| 08/27/2003 | EP1338651A1 Method of screening remedy for diabetes |
| 08/27/2003 | EP1338608A2 Protein complexes and methods for their use |
| 08/27/2003 | EP1338607A2 Antigenic iron repressible proteins from n. meningitidis related to the heolysin family of toxins |
| 08/27/2003 | EP1338606A1 Nucleic Acid encoding an HERV-H polypeptide for diagnosing colorectal cancer |
| 08/27/2003 | EP1338198A1 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse |
| 08/27/2003 | EP1337850A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 08/27/2003 | EP1337849A2 Methods and compositions for sorting and/or determining microorganisms |
| 08/27/2003 | EP1337846A1 Arrangement for the production testing and archiving of chemical or biological arrays bonded to a solid phase |
| 08/27/2003 | EP1337845A2 Method for analyzing mass spectra |